Contributors: Special thanks to Professor Ugo Corrà
Based on the 2016 ESC Guidelines on CVD Prevention in Clinical Practice
Webinars on this topic
2016 ESC webinar on "New ESC CVD prevention guidelines 2016: how should they change my clinical practice in preventive cardiology?" streamed live on 21 Feb 2017: Watch the recording.
Part 1 - Overview of the Guidelines
| Session title |
Slides |
Webcast |
| 2016 European Guidelines on cardiovascular disease prevention in clinical practice. Cardiovascular risk assessment for a busy clinician |
|
|
| 2016 European Guidelines on cardiovascular disease prevention in clinical practice. Do we need an ECG before starting physical activity? |
|
|
Part 2 - Topics in focus
| Topic/Section |
Session title |
Slides |
Webcast |
| A naturally randomised trial comparing the effect of long-term exposure to lower LDL-C, lower SBP, or both on the risk of cardiovascular disease. |
Meet the Trialist III |
|
|
| Are clinicians following statin intensity recommendations? Insights in 135 U.S community practices in the PALM registry |
Breaking down barriers in secondary prevention |
|
|
| Management of overweight and obesity in patients at high cardiovascular risk across Europe: Results from EUROASPIRE IV survey |
Breaking down barriers in secondary prevention |
|
|
| Barriers to uptake of cardio-protective treatment in a community elderly population of stage B heart failure |
Breaking down barriers in secondary prevention |
|
|
| What the Guidelines tell us. Behavioural change in the non-compliant high-risk patient |
Primary prevention |
|
|
| Can exercise make the difference? Benefits of exercise training |
After CRT |
|
|
| can technology help? Can mobile apps help prevent cardiovascular disease across the life span? |
Engaging patients to self-manage |
|
|
| Can technology help? |
What works in smoking cessation in heart disease? |
|
|
| Children’s modern lifestyle – Between fit and fat. |
Cardiovascular risk factors in children and youth: a call for action |
|
|
| Evidence-based management of psychosocial risk factors |
Should we consider psychosocial determinants of cardiovascular disease? |
|
|
| Gaps in knowledge and implementation strategies: what do we know? |
Secondary prevention after myocardial infarction: how can we go further? |
|
|
| How to bring sex into the consultation? |
Let's talk about sex! Important for patients - Difficult for professionals |
|
|
| Importance of health systems and public health to overcome barriers in regional CVD prevention |
How should the global cardiology community respond to the preventable global epidemic of CVD? |
|
|
| Multiple facets of collaboration: a European assessment of cardiologists needs in relation to education, guidelines, research and roles of their specialty society |
The future is in education |
|
|
Our mission: To reduce the burden of cardiovascular disease.